Stock A078160 MEDIPOST CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company MEDIPOST Co., Ltd.

Equities

A078160

KR7078160009

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 29/05/2024 am IST 		5-day change 1st Jan Change
6,850 KRW +1.33% Intraday chart for MEDIPOST Co., Ltd. -1.86% -16.05%
24/04 Medip MEDIPOST CDMO Co., Ltd. announced that it has received KRW 30 billion in funding from MEDIPOST Co., Ltd. CI
23/04 Medip MEDIPOST CDMO Co., Ltd. announced that it expects to receive KRW 30 billion in funding from MEDIPOST Co., Ltd. CI

Business Summary

MEDIPOST Co., Ltd. is a Korea-based company engaged in the biotechnology business. The Company mainly operates cord blood banks. Its cord blood banks consist of public cord blood bank, which provides resource to anyone who may need to undergo hematopoietic stem cell transplantation (HSCT) as a result of blood-related diseases, such as leukemia or aplastic anemia, as well as family cord blood bank, which provides services for storing newborn’s cord blood exclusively for family’s use. It also involves in the provision of stem cell drugs, which are used for recovery of knee articular cartilage and others, distribution of healthcare food and natural cosmetics, as well as provision of healthcare services.

Number of employees: 289

Sales per Business

KRW in Million2022Weight2023Weight Delta
Cord Blood
47.6 %
29,511 46.0 % 32,694 47.6 % +10.79%
Cell Therapy
31.4 %
19,460 30.3 % 21,576 31.4 % +10.87%
Health Functional Food
13.9 %
9,881 15.4 % 9,552 13.9 % -3.33%
Other
7.0 %
5,349 8.3 % 4,821 7.0 % -9.86%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
64,025 99.7 % 68,643 100.0 % +7.21%

Managers

Managers TitleAgeSince
Won-Il Oh CEO
 Chief Executive Officer 61 26/00/26
Soo-Jin Choi CTO
 Chief Tech/Sci/R&D Officer 52 12/02/12
Jang-Won Lee BRD
 Director/Board Member 58 01/10/01
Dong-Jin Hwang BRD
 Director/Board Member 62 02/06/02
Jang-young Lee PRN
 Corporate Officer/Principal 57 11/12/11
Hye-Kyung Hong PRN
 Corporate Officer/Principal 55 -

Members of the board

Members of the board TitleAgeSince
Won-Il Oh CEO
 Chief Executive Officer 61 26/00/26
Jae-Wook Oh BRD
 Director/Board Member 62 30/12/30
Hyun-Ki Min BRD
 Director/Board Member 59 30/12/30
Dong-Jin Hwang BRD
 Director/Board Member 62 02/06/02
Jang-Won Lee BRD
 Director/Board Member 58 01/10/01
Jin-Heon Kim BRD
 Director/Board Member 62 29/13/29
Yeo-Sun Han BRD
 Director/Board Member 59 29/22/29
Je-Won Lee BRD
 Director/Board Member 59 29/22/29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 34,217,785 20,574,442 ( 60.13 %) 119,000 ( 0.3478 %) 60.13 %
Stock B 0 3,740,314 0 0

Shareholders

NameEquities%Valuation
Crescendo Equity Partners Ltd.
27.35 %
9,358,671 27.35 % 48 M ₩
Skylake Equity Patners Ltd.
25.52 %
8,733,612 25.52 % 45 M ₩
Yoon-Sun Yang
1.918 %
656,176 1.918 % 3 M ₩
MEDIPOST CO., LTD.
0.3956 %
135,372 0.3956 % 694 441 ₩
Won-Il Oh
0.2410 %
82,449 0.2410 % 422 953 ₩
INTRON BIOTECHNOLOGY, INC.
0.1885 %
64,512 0.1885 % 330 938 ₩
Jang-Won Lee
0.0614 %
21,000 0.0614 % 107 727 ₩
KB Asset Management Co. Ltd.
0.0317 %
10,840 0.0317 % 55 608 ₩
Pension Reserves Investment Management Board
0.009860 %
3,374 0.009860 % 17 308 ₩
Medipost Co., Ltd. Employee Stock Ownership Association
0.005985 %
2,048 0.005985 % 10 506 ₩
NameEquities%Valuation
Skylake Equity Patners Ltd.
48.62 %
2,423,821 48.62 % 12 M ₩
Crescendo Equity Partners Ltd.
48.22 %
2,403,678 48.22 % 12 M ₩

Holdings

NameEquities%Valuation
MEDIPOST CO., LTD.
0.40%
 135,372 0.40% 694,441 $
INTRON BIOTECHNOLOGY, INC.
0.17%
 56,710 0.17% 285,991 $

Company contact information

MEDIPOST Co., Ltd.

21 Daewangpangyo-ro 644 beon-gil Bundang-gu

13494, Seongnam

+

http://www.medi-post.co.kr
address MEDIPOST Co., Ltd.(A078160)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MEDIPOST CO., LTD. Stock MEDIPOST Co., Ltd.
-16.05% 171M
MODERNA, INC. Stock Moderna, Inc.
+48.40% 56.69B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.80% 41B
LONZA GROUP AG Stock Lonza Group AG
+38.14% 38.11B
CELLTRION, INC. Stock Celltrion, Inc.
-11.22% 26.89B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+15.55% 25.59B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.03% 18.59B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.32% 12.39B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.89% 11.99B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+22.74% 11.88B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A078160 Stock
  4. Company MEDIPOST Co., Ltd.